FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100523555> ?p ?o ?g. }

• W2100523555 endingPage "578" @default.
• W2100523555 startingPage "557" @default.
• W2100523555 abstract "Autoimmune mucocutaneous blistering diseases (AMBD) are an interesting group of rare diseases that affect the mucous membranes and the skin and are frequently or potentially fatal. The clinical presentation is significantly variable, as is the course and prognosis. The immunopathology is well characterized and the target antigens to which the autoantibodies are directed have been studied by various investigators. A significant majority of the patients respond to conventional therapy, which consists of high-dose long-term systemic corticosteroids and immunosuppressive agents. This treatment program has significantly improved the prognosis in many patients. In such patients, significant side effects of the drugs may appear and produce a very poor quality of life. In patients with progressive diseases, especially those with mucous membrane pemphigoid, the significant sequela; such as blindness, aphonia, and stenosis of the anal and vaginal canals can occur. In several patients treated with conventional immunosuppressive therapy, death occurs as a consequence of prolonged immune suppression leading to opportunistic infections. In this manuscript, the published data on the use of immunoglobulins intravenous (IGIV) in patients with AMBD is presented. The most important features of IGIV in patients with AMBD are: 1) the ability to clinically control the disease; 2) the ability to induce and maintain a long-term clinical remission; 3) a lower incidence of side effects; and 4) a higher quality of life. The important characteristic of the IGIV therapy in the AMBD is two-fold. First, the therapy, when given according to a published protocol, produces a lasting and long-term clinical remission, rather than a temporary arrest of the disease. Second, the therapy, as described in the protocol, has a very definitive endpoint. Consequently, once the patients are treated and go into long-term remission, the therapy is no longer required. The significant positive results obtained with IGIV are to a large extent also due to the associated aggressive topical therapy that was used and the frequent use of sublesional injections with triamcinolone. The rapid and early detection of cutaneous and mucosal infections and their treatment with systemic antibiotics is also a very important feature of IGIV therapy. When patients are under long-term conventional therapy, the infections are often not detected because they lack the ability to mount signs of inflammation. It is also becoming increasingly clear for patients to have a successful outcome, in treatment with IGIV therapy, it is critical that the physician spends a significant amount of time with each patient, monitor the therapy closely, and be familiar with the overall health of the patient. It is also best if the therapies are instituted by a physician who has significant interest and experience in blistering diseases and IGIV therapy." @default.
• W2100523555 created "2016-06-24" @default.
• W2100523555 creator A5061811305 @default.
• W2100523555 date "2006-04-01" @default.
• W2100523555 modified "2023-10-13" @default.
• W2100523555 title "Use of intravenous immunoglobulin therapy in autoimmune blistering diseases" @default.
• W2100523555 cites W1573781527 @default.
• W2100523555 cites W188853335 @default.
• W2100523555 cites W1966213173 @default.
• W2100523555 cites W1967983427 @default.
• W2100523555 cites W1968887871 @default.
• W2100523555 cites W1968972064 @default.
• W2100523555 cites W1969087167 @default.
• W2100523555 cites W1969222347 @default.
• W2100523555 cites W1977397535 @default.
• W2100523555 cites W1980588421 @default.
• W2100523555 cites W1980886599 @default.
• W2100523555 cites W1981084641 @default.
• W2100523555 cites W1985808037 @default.
• W2100523555 cites W1986354631 @default.
• W2100523555 cites W1989909962 @default.
• W2100523555 cites W1991573183 @default.
• W2100523555 cites W1994646633 @default.
• W2100523555 cites W1997484326 @default.
• W2100523555 cites W2000345353 @default.
• W2100523555 cites W2000698364 @default.
• W2100523555 cites W2004474855 @default.
• W2100523555 cites W2004727503 @default.
• W2100523555 cites W2005370768 @default.
• W2100523555 cites W2006019631 @default.
• W2100523555 cites W2009126581 @default.
• W2100523555 cites W2010287671 @default.
• W2100523555 cites W2011191872 @default.
• W2100523555 cites W2013526408 @default.
• W2100523555 cites W2013863167 @default.
• W2100523555 cites W2015097756 @default.
• W2100523555 cites W2017399322 @default.
• W2100523555 cites W2020928345 @default.
• W2100523555 cites W2022106567 @default.
• W2100523555 cites W2024136187 @default.
• W2100523555 cites W2025274312 @default.
• W2100523555 cites W2026129217 @default.
• W2100523555 cites W2027916433 @default.
• W2100523555 cites W2029273508 @default.
• W2100523555 cites W2030375457 @default.
• W2100523555 cites W2034107517 @default.
• W2100523555 cites W2034775711 @default.
• W2100523555 cites W2038701140 @default.
• W2100523555 cites W2040746092 @default.
• W2100523555 cites W2043581139 @default.
• W2100523555 cites W2051070057 @default.
• W2100523555 cites W2053026285 @default.
• W2100523555 cites W2053257655 @default.
• W2100523555 cites W2053442213 @default.
• W2100523555 cites W2055739156 @default.
• W2100523555 cites W2055975319 @default.
• W2100523555 cites W2060866289 @default.
• W2100523555 cites W2061789970 @default.
• W2100523555 cites W2062010080 @default.
• W2100523555 cites W2063536378 @default.
• W2100523555 cites W2064020036 @default.
• W2100523555 cites W2064147984 @default.
• W2100523555 cites W2065847778 @default.
• W2100523555 cites W2065900461 @default.
• W2100523555 cites W2066031863 @default.
• W2100523555 cites W2068021720 @default.
• W2100523555 cites W2069376212 @default.
• W2100523555 cites W2070700221 @default.
• W2100523555 cites W2070842905 @default.
• W2100523555 cites W2071156417 @default.
• W2100523555 cites W2072014644 @default.
• W2100523555 cites W2073436919 @default.
• W2100523555 cites W2073502103 @default.
• W2100523555 cites W2073512163 @default.
• W2100523555 cites W2073867916 @default.
• W2100523555 cites W2074940561 @default.
• W2100523555 cites W2076590149 @default.
• W2100523555 cites W2080572514 @default.
• W2100523555 cites W2081598981 @default.
• W2100523555 cites W2084189323 @default.
• W2100523555 cites W2087014203 @default.
• W2100523555 cites W2090544680 @default.
• W2100523555 cites W2092942712 @default.
• W2100523555 cites W2094487977 @default.
• W2100523555 cites W2094551801 @default.
• W2100523555 cites W2098708745 @default.
• W2100523555 cites W2099176959 @default.
• W2100523555 cites W2101905310 @default.
• W2100523555 cites W2103294754 @default.
• W2100523555 cites W2108717668 @default.
• W2100523555 cites W2109460539 @default.
• W2100523555 cites W2110332942 @default.
• W2100523555 cites W2112167780 @default.
• W2100523555 cites W2118171083 @default.
• W2100523555 cites W2123531321 @default.
• W2100523555 cites W2125076165 @default.
• W2100523555 cites W2127411895 @default.
• W2100523555 cites W2130264575 @default.

• next